Endoxifen Approval for Bipolar Disorder in India: A Premature or a Pragmatic Decision?

J Clin Psychopharmacol. 2023 Jan-Feb;43(1):3-5. doi: 10.1097/JCP.0000000000001643.

Authors

Rishab Gupta¹, Swarndeep Singh²

Affiliations

¹ From the Behavioral Neurology & Neuropsychiatry Fellow, Department of Psychiatry, Brigham and Women's Hospital/Harvard Medical School, Boston, MA.
² Assistant Professor, Government Medical College and Hospital, Chandigarh, India.

PMID: 36584243
DOI: 10.1097/JCP.0000000000001643

Abstract

In this commentary, we critique the Indian government's decision to approve endoxifen for the treatment of acute mania among adults.

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

MeSH terms

Adult
Bipolar Disorder* / drug therapy
Humans
India
Mania

Substances

4-hydroxy-N-desmethyltamoxifen